How reimbursement risks gave lenders the keys to Webster's splashiest healthcare bets
When Matilda Jane Clothing, a girl’s apparel brand backed by Webster Capital, abruptly closed its doors in 2022, the deal was already practically out of sight from Webster’s rearview mirror. The firm had moved on from consumer investing entirely and made an all-in bet on healthcare investing: It had a new focus, a fresh $1.7bn fund ready to deploy, and a new name. Children’s clothing companies were a problem of the past.
